Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Innovative Industrial Properties, Inc. (IIPR)
NYSEReal EstateReit - IndustrialSnapshot 2026-11-05
$55.30-1.83%
Close 2026-11-05 · 1-day change
NYSEReal EstateReit - IndustrialSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
4.37 → 4.37 EPS · FY ending Dec 31, 2027 · 3 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 3; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for IIPR yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Manage capital allocation to strengthen balance sheet | A supporting condition in Innovative Industrial Properties, Inc.'s published investment case. The stated target is maintain or improve credit metrics and continue disciplined capital use. | Improving | significant deterioration in credit metrics or capital misuse | Qualitative: $282M debt repaid, Q3 beat Q3 2026 earnings beat estimates; $282M senior notes repaid in May 2026; recent debt issuance and amendments noted. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a real estate investment trust with a multi-year view that depends on continued operating strength and management’s use of capital. The thesis is intact, and the latest signal has shifted from mixed to mildly favorable, though management execution remains volatile.
The valuation evidence describes IIPR as cheap versus peers, with an expectations gap of -0.17 and low fragility in what is priced in. This suggests the market is not relying on a fragile mix of expensive valuation, weak execution, and turbulence, but the evidence does not detail specific market expectations.
Recent financial performance is strong and in the top half of the industry, while near-term miss risk is rated quiet at 25%. Management has maintained the quarterly dividend and made progress on investments and capital allocation, although recent event signals include a negative capital-allocation item. The evidence supports a sound near-term operating picture, but earnings quality is neutral and management execution is volatile.
The multi-year view benefits if the Fed begins cutting rates and if IIPR delivers another quarterly result like its recent 8% beat. It faces a weaker sector backdrop if major real estate peers report missed results or soft guidance. Continued investment activity, capital allocation, and dividend consistency also matter, though the evidence does not establish how these will develop beyond current plans and progress.
Over the next 1 to 3 years, the thesis rests on strong operating results continuing while management execution and real estate sector conditions remain supportive. The valuation is cheap versus peers, but the evidence is medium-confidence and the swing factors remain meaningful. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Maintain dividend per share at $1.90 | Innovative Industrial Properties keeps paying a steady $1.90 dividend per share. | Intact | dividend per share falls below $1.90 next 4 quarters | Dividend per share: $1.90 per share FY2026-Q3; GAAP. Published target: >= $1.90 per share. Target period is not explicitly aligned with this observation. Nov 3, 20261.9 USD/share · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Engage in mergers and acquisitions to expand portfolio | Leasing growth and M&A activity support portfolio expansion. | Improving | no material M&A activity within 12 months | Qualitative condition This condition has no defined numerical measure. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Achieve positive revenue growth | A supporting condition in Innovative Industrial Properties, Inc.'s published investment case. The stated target is >= 3% YoY revenue growth. | Improving | revenue growth falls below 0% in FY27 | Revenue growth: 0.36% FY2026-Q3; GAAP. Published target: >= 3% YoY revenue growth. Annual target cannot be compared with a quarterly or TTM observation. Nov 3, 20260.363299 percent · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$4.79 → $4.37 · observed estimates
$0.29B → $0.26B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $4.79 | $287,990,000 | 1 / 2 |
| 2026-07-25 | $4.79 | $287,990,000 | 1 / 2 |
| 2026-07-26 | $4.79 | $281,554,300 | 1 / 2 |
| 2026-07-27 | $4.79 | $283,895,000 | 2 / 2 |
| 2026-07-28 | $4.79 | $283,895,000 | 2 / 2 |
| 2026-07-29 | $4.79 | $281,554,300 | 1 / 2 |
| 2026-07-30 | $4.79 | $281,554,300 | 1 / 2 |
| 2026-07-31 | $4.79 | $281,554,300 | 1 / 2 |
| 2026-08-01 | $4.79 | $283,895,000 | 2 / 2 |
| 2026-08-02 | $4.79 | $283,895,000 | 2 / 2 |
| 2026-08-03 | $4.79 | $281,554,300 | 1 / 2 |
| 2026-08-04 | $4.79 | $277,009,530 | 1 / 3 |
| 2026-08-05 | $4.79 | $277,009,530 | 1 / 3 |
| 2026-08-06 | $4.79 | $277,009,530 | 1 / 3 |
| 2026-08-07 | $4.79 | $266,160,000 | 1 / 3 |
| 2026-08-08 | $4.79 | $266,160,000 | 1 / 3 |
| 2026-08-09 | $4.79 | $271,876,200 | 1 / 3 |
| 2026-08-10 | $4.79 | $266,160,000 | 1 / 3 |
| 2026-08-12 | $4.79 | $273,854,300 | 1 / 2 |
| 2026-08-13 | $4.79 | $266,160,000 | 1 / 3 |
| 2026-08-14 | $4.79 | $266,160,000 | 1 / 3 |
| 2026-08-15 | $4.79 | $266,160,000 | 1 / 2 |
| 2026-08-16 | $4.79 | $266,160,000 | 1 / 2 |
| 2026-08-17 | $4.79 | $266,160,000 | 1 / 2 |
| 2026-08-18 | $4.79 | $266,160,000 | 2 / 3 |
| 2026-08-19 | $4.79 | $266,160,000 | 2 / 3 |
| 2026-08-20 | $4.39 | $265,711,666 | 1 / 3 |
| 2026-08-21 | $4.39 | $265,711,666 | 1 / 3 |
| 2026-08-22 | $4.39 | $265,711,666 | 1 / 3 |
| 2026-08-23 | $4.39 | $265,711,666 | 1 / 3 |
| 2026-08-24 | $4.39 | $265,711,666 | 1 / 3 |
| 2026-08-25 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-08-26 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-08-27 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-08-28 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-08-29 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-08-30 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-08-31 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-01 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-02 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-03 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-04 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-05 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-06 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-07 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-08 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-09 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-10 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-11 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-12 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-13 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-14 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-15 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-16 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-17 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-18 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-19 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-20 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-21 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-22 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-23 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-24 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-25 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-26 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-27 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-28 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-29 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-09-30 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-10-01 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-10-02 | $4.46 | $266,558,800 | 1 / 3 |
| 2026-10-03 | $4.37 | $266,558,800 | 1 / 3 |
| 2026-10-04 | $4.37 | $266,558,800 | 1 / 3 |
| 2026-10-05 | $4.37 | $266,558,800 | 1 / 4 |
| 2026-10-06 | $4.37 | $266,558,800 | 1 / 4 |
| 2026-10-07 | $4.37 | $266,558,800 | 1 / 4 |
| 2026-10-08 | $4.37 | $266,558,800 | 1 / 4 |
| 2026-10-09 | $4.37 | $266,558,800 | 1 / 4 |
| 2026-10-10 | $4.37 | $266,558,800 | 1 / 4 |
| 2026-10-11 | $4.37 | $266,558,800 | 1 / 4 |
| 2026-10-12 | $4.37 | $266,558,800 | 1 / 4 |
| 2026-10-13 | $4.37 | $263,833,800 | 1 / 4 |
| 2026-10-14 | $4.37 | $263,833,800 | 1 / 4 |
| 2026-10-15 | $4.37 | $258,003,640 | 1 / 4 |
| 2026-10-16 | $4.37 | $258,003,640 | 1 / 5 |
| 2026-10-17 | $4.37 | $258,003,640 | 1 / 5 |
| 2026-10-18 | $4.37 | $258,003,640 | 1 / 5 |
| 2026-10-19 | $4.37 | $258,003,640 | 1 / 5 |
| 2026-10-20 | $4.37 | $258,003,640 | 1 / 5 |
| 2026-10-21 | $4.37 | $258,003,640 | 2 / 5 |
| 2026-10-22 | $4.37 | $258,003,640 | 2 / 5 |
| 2026-10-23 | $4.37 | $258,003,640 | 3 / 5 |
| 2026-10-24 | $4.37 | $258,003,640 | 3 / 5 |
| 2026-10-25 | $4.37 | $258,003,640 | 3 / 5 |
| 2026-10-26 | $4.37 | $258,003,640 | 3 / 5 |
| 2026-10-27 | $4.37 | $258,003,640 | 3 / 5 |
| 2026-10-28 | $4.37 | $258,003,640 | 3 / 5 |
| 2026-10-29 | $4.37 | $258,003,640 | 3 / 5 |
| 2026-10-30 | $4.37 | $258,003,640 | 3 / 5 |
| 2026-10-31 | $4.37 | $258,003,640 | 3 / 5 |
| 2026-11-01 | $4.37 | $256,859,640 | 3 / 5 |
| 2026-11-02 | $4.37 | $256,859,640 | 3 / 5 |
| 2026-11-03 | $4.37 | $256,859,640 | 3 / 5 |
| 2026-11-04 | $4.37 | $255,688,040 | 3 / 5 |
| 2026-11-05 | $4.37 | $255,688,040 | 3 / 5 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 4 Hold · 1 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 2 recorded
0 raises · 0 cuts · 0 unchanged · 1 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.